Clinical Trial: A Clinical Trial to Assess the Pharmacokinetics, Safety, and Food Effect of AD-230 in Healthy Adults

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618845) titled 'A Clinical Trial to Assess the Pharmacokinetics, Safety, and Food Effect of AD-230 in Healthy Adults' on May 26.

Brief Summary: A clinical trial to assess the pharmacokinetics, safety, and food effect of AD-230 in healthy adults

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Chronic Liver Disease (CLD)

Intervention: DRUG: AD-230 (Fasted)

AD-230 1Tab., Per Oral, Fasted

DRUG: AD-230 (Fed)

AD-230 1 Tab., Per Oral, Fed state

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Addpharma Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....